# Effects of Dexmedetomidine on Oxygenation and Lung Mechanics in Morbidly Obese Patients Undergoing Bariatric Operations

> **NCT02843698** · PHASE4 · COMPLETED · sponsor: **Cairo University** · enrollment: 42 (actual)

## Conditions studied

- Restrictive Lung Disease

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT02843698
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2017-08-26
- **Final completion:** 2017-08-26
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2017-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02843698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02843698, "Effects of Dexmedetomidine on Oxygenation and Lung Mechanics in Morbidly Obese Patients Undergoing Bariatric Operations". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02843698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*